Top Cited Articles
Acceptance rate:
40%
Time to first decision with review (median):
35 days*
Acceptance to publication:
22 days*
Impact Factor (JCR):
4.8
Citescore:
6.7
Total content views:
438,900
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors
Human papillomavirus-independent cervical cancer
ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer
European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery
Management of pregnancy in women with cancer
Uterine serous carcinoma: key advances and novel treatment approaches
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program
Clear cell carcinoma of the ovary: a clinical and molecular perspective
Evaluating meaningful levels of financial toxicity in gynecologic cancers
SUCCOR cone study: conization before radical hysterectomy
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)
Advances in immunotherapy for cervical cancer: recent developments and future directions
Imaging modalities in pregnant cancer patients
The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of life
Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management
Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001
Predictive role of serum cholesterol and triglycerides in cervical cancer survival